← Scroll for more →
Palvella Therapeutics, Inc. (PVLA)
Pharmaceutical Preparations
Latest Price
$162.28
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
15.12
P/B Ratio
10.73
Institutional Ownership
99.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Montanova Capital, LLC | 1.14M | $173.0M | 7.89% | -18.1K | 2026-06-30 |
| Jennison Associates LLC | 960.6K | $146.0M | 6.67% | +320.0K | 2026-06-30 |
| BlackRock, Inc. | 918.4K | $140.0M | 6.38% | +231.5K | 2026-06-30 |
| Frazier Life Sciences Management, L.P. | 882.4K | $134.0M | 6.13% | -- | 2026-06-30 |
| First Light Asset Management, LLC | 771.9K | $117.0M | 5.36% | -208.9K | 2026-06-30 |
| Bvf Inc | 672.8K | $102.0M | 4.67% | -288.2K | 2026-06-30 |
| State Street Corp | 653.2K | $99.0M | 4.54% | +194.2K | 2026-06-30 |
| Price T Rowe Associates Inc | 638.9K | $97.0M | 4.44% | +236.3K | 2026-06-30 |
| Vanguard Capital Management LLC | 513.8K | $78.0M | 3.57% | +36.5K | 2026-06-30 |
| Frontier Capital Management Co LLC | 478.8K | $73.0M | 3.33% | +104.8K | 2026-06-30 |